Initiating insulin treatment in insulin-requiring type 2 diabetic patients: Comparative efficiency and cost of outpatient and inpatient management

Diabetes and Metabolism

Volumn 24, Issue 2, 1998, Pages 137-142

  Penfornis, A ^a,c   Millot, L ^b   Attali, J R ^d   Balarac, N ^d   Bercovici, J P ^d   Bourgon, C ^d   Bresson, R ^d   Courreges, J P ^d   Duvezin, P ^d   Estour, B ^d   Fontaine, P ^d   Halfon, P ^d   Halimi, S ^d   Kressman, J ^d   Leutenegger, M ^d   Mollet, E ^d   Passa, P ^d   Rubin, P ^d   Thervet, F ^d   Thivolet, C ^d  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

^b SERVICE DE NEUROLOGIE   (France)

^c UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^d NONE

Author keywords

Costs; Glycaemic control; HbA1c; Insulin requiring non insulin dependent diabetes mellitus; Outpatients; Safety

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ISOPHANE INSULIN; NEUTRAL INSULIN;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HOSPITAL PATIENT; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN TREATMENT; KETONURIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT; RANDOMIZED CONTROLLED TRIAL;

EID: 7144263732     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Chase HP, Crews KR, Garg S, et al. Outpatient management vs in-hospital management of children with new-onset diabetes. Clinical Pediatrics, 1992, 31, 450-456.
2. Wilson RM, Clarke P, Barkes H, Heller SR, Tattersall RB. Starting insulin treatment as an outpatient : report of 100 consecutive patients followed up for at least one year. JAMA, 1986, 256, 877-880.
3. Swift PGF, Hearnshaw JR, Botha JL, Wnght G, Raymond NT, Jamieson KF. A decade of diabetes : keeping children out of hospital. Br Med J, 1993, 307, 96-98.
4. Estour B, Fourel E, Voitellier P. Continuous subcutaneous insulin infusion for initial treatment of Type 1 diabetes mellitus. Pilot study for an outpatient starting insulin treatment. Diabete Metab, 1993, 19, 514-517.
5. Papoz L, Vauzelle F, Vexiau P, Cathelineau G. Pattern of treatment among diabetic patients in France. Diabetes Care, 1988, 7, 586-591.
6. Papoz L, the EURODIAB Subarea C Study Group. Utilization of drug sales data for the epidemiology of chronic diseases: the example of diabetes. Epidemiology, 1993, 4, 421-427.
7. Gallus G, Repetto F, Micossi P, Garancini P, Calori G, Pozza G. Stima dell'incidenza e della prevalenza in Italia del diabete mellito noto sulla base di statistiche correnti. G Ital Diabetol, 1988, 8, 15-22.
8. Krosnick A. Economic impact of type II diabetes mellitus. Primary Care, 1985, 15, 423-432.
9. Everhart J, Knowler WC, Bennet PH. Incidence and risk factors for non-insulin-dependent diabetes. In : Harris, Hamman, eds. Diabetes in America, NIH Publication (No. 85-1468) National Institutes of Health, Besthesda: IV.1, 1985.
10. Nielsen NV, Hemmingsen L. Prevalence of diabetes mellitus treated with insulin and oral hypoglycaemic agents in Denmark. Diabetes Res, 1986, 3, 423-425.
11. Reunanen A. Prevalence and incidence of type 2 diabetes in Finland. Acta Endocrinol. 1984, 105 (Suppl 262), 31-35.
12. Triomphe A. The socio-economic cost of diabetic complications in France. Diabetic Med, 1991, 8, S30-S32.
13. Huse DM, Oster G, Killen AR, Lacey MJ, Colditz GA. The economic costs of non-insulin-dependent diabetes mellitus. JAMA, 1989, 262, 2708-13.
14. Blazy D, Nguyen M. The French diabetic population: study of a representative sample. Diabete Melab, 1993, 19, 483-90.
15. Genuth S. Insulin use in NIDDM. Diabetes Care, 1990, 13, 1240-64.
16. Charbonnel B. L'insulinothérapie est-elle suffisamment utilisée dans le traitement du diabète de Type II ? Insulinothérapie minimale ou insulinothérapie intensifiée ? Diabete Metab, 1995, 21, 219-24.
17. Overland J, McGill M, Yue DK. Ambulatory diabetes care : a diabetes centre based model. Practical Diabetes International, 1997, 14, 111-5.